NO157700C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido(1,4)benzodiazepiner. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido(1,4)benzodiazepiner.

Info

Publication number
NO157700C
NO157700C NO813839A NO813839A NO157700C NO 157700 C NO157700 C NO 157700C NO 813839 A NO813839 A NO 813839A NO 813839 A NO813839 A NO 813839A NO 157700 C NO157700 C NO 157700C
Authority
NO
Norway
Prior art keywords
benzodiazepines
preparation
therapeutic active
analogue procedure
active pyrido
Prior art date
Application number
NO813839A
Other languages
English (en)
Norwegian (no)
Other versions
NO157700B (no
NO813839L (no
Inventor
Chandler Roy Taylor Jr
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of NO813839L publication Critical patent/NO813839L/no
Priority to NO872271A priority Critical patent/NO872271D0/no
Priority to NO872272A priority patent/NO161175C/no
Publication of NO157700B publication Critical patent/NO157700B/no
Publication of NO157700C publication Critical patent/NO157700C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO813839A 1981-09-24 1981-11-12 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido(1,4)benzodiazepiner. NO157700C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO872271A NO872271D0 (no) 1981-09-24 1987-05-29 (2-((aminopyridinyl)amino)fenyl)-arylmethanoner.
NO872272A NO161175C (no) 1981-09-24 1987-05-29 Pyrido(1,4)-benzodiazepiner.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30508081A 1981-09-24 1981-09-24

Publications (3)

Publication Number Publication Date
NO813839L NO813839L (no) 1983-03-25
NO157700B NO157700B (no) 1988-01-25
NO157700C true NO157700C (no) 1988-05-04

Family

ID=23179241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813839A NO157700C (no) 1981-09-24 1981-11-12 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido(1,4)benzodiazepiner.

Country Status (27)

Country Link
JP (1) JPS5865290A (ja)
KR (1) KR890000764B1 (ja)
BE (1) BE891666A (ja)
CA (1) CA1199324A (ja)
CH (1) CH651833A5 (ja)
DE (1) DE3150522A1 (ja)
DK (3) DK186282A (ja)
EG (1) EG15904A (ja)
ES (6) ES507971A0 (ja)
FI (1) FI71935C (ja)
FR (1) FR2515183B1 (ja)
GR (1) GR78473B (ja)
HU (2) HU189426B (ja)
IE (1) IE52493B1 (ja)
IL (1) IL64284A (ja)
IN (1) IN156080B (ja)
IT (1) IT1146728B (ja)
LU (1) LU83865A1 (ja)
NL (1) NL8200549A (ja)
NO (1) NO157700C (ja)
NZ (1) NZ198999A (ja)
PH (2) PH17847A (ja)
PL (6) PL143596B1 (ja)
PT (1) PT74286B (ja)
SE (2) SE448629B (ja)
YU (1) YU46128B (ja)
ZA (1) ZA817866B (ja)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825549A (en) * 1972-10-24 1974-07-23 Squibb & Sons Inc Certain dihydropyrido(2,1-b)(1,3)benzodi-azepines and benzodiazocines
DE2424811C3 (de) * 1974-05-22 1981-08-20 Dr. Karl Thomae Gmbh, 7950 Biberach Pyrido-benzodiazepinone, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SE422799B (sv) * 1975-05-28 1982-03-29 Merck & Co Inc Analogiforfarande for framstellning av 1,3-dihydroimidazo (4,5-b)pyridin-2-oner

Also Published As

Publication number Publication date
PH20536A (en) 1987-02-09
DK403387A (da) 1987-08-03
DK403487D0 (da) 1987-08-03
SE8600688D0 (sv) 1986-02-17
NL8200549A (nl) 1983-04-18
SE8106573L (sv) 1983-03-25
EG15904A (en) 1987-03-30
CA1199324A (en) 1986-01-14
KR890000764B1 (ko) 1989-04-05
PL137068B1 (en) 1986-04-30
FI71935C (fi) 1987-03-09
ES516052A0 (es) 1984-01-16
FR2515183A1 (fr) 1983-04-29
FR2515183B1 (fr) 1986-11-14
CH651833A5 (fr) 1985-10-15
PL143596B1 (en) 1988-02-29
KR830009058A (ko) 1983-12-17
PH17847A (en) 1985-01-09
NO157700B (no) 1988-01-25
ES526563A0 (es) 1986-02-01
ES8604531A1 (es) 1986-02-01
FI71935B (fi) 1986-11-28
NO813839L (no) 1983-03-25
PL138859B1 (en) 1986-11-29
ES526562A0 (es) 1985-04-01
DK403487A (da) 1987-08-03
YU46128B (sh) 1993-05-28
PL143597B1 (en) 1988-02-29
HUT34732A (en) 1985-04-28
ES8402295A1 (es) 1984-01-16
PL241409A1 (en) 1984-05-21
IE52493B1 (en) 1987-11-25
BE891666A (fr) 1982-04-16
JPS5865290A (ja) 1983-04-18
PL241410A1 (en) 1984-01-02
FI813976L (fi) 1983-03-25
ES8504148A1 (es) 1985-04-01
IT8168605A0 (it) 1981-12-09
PL139381B1 (en) 1987-01-31
IL64284A (en) 1986-12-31
PL143322B1 (en) 1988-02-29
ES516051A0 (es) 1983-09-16
ES543328A0 (es) 1986-06-01
ES8303348A1 (es) 1983-02-01
ES8308563A1 (es) 1983-09-16
ZA817866B (en) 1982-10-27
IN156080B (ja) 1985-05-11
LU83865A1 (fr) 1983-09-02
PT74286A (en) 1982-02-01
YU62582A (en) 1986-04-30
IL64284A0 (en) 1982-02-28
DK186282A (da) 1983-03-25
IT1146728B (it) 1986-11-19
SE455305B (sv) 1988-07-04
NZ198999A (en) 1987-07-31
PT74286B (en) 1983-06-27
DE3150522A1 (de) 1983-04-07
GR78473B (ja) 1984-09-27
ES8607726A1 (es) 1986-06-01
SE448629B (sv) 1987-03-09
DK403387D0 (da) 1987-08-03
ES507971A0 (es) 1983-02-01
IE812769L (en) 1983-03-24
HU187393B (en) 1985-12-28
HU189426B (en) 1986-07-28
PL234426A1 (en) 1984-01-02
SE8600688L (sv) 1986-02-17

Similar Documents

Publication Publication Date Title
NO158100C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (4,5-c)pyridinderivater.
NO159724C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazo(1,2-a)-pyraziner.
NO821198L (no) Fremgangsmaate for fremstilling av preparater for behandling av melanomer.
NO158419C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner.
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
NO157819C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo (1,2-a)-pyridin-2-yl-karbostyrilforbindelser.
NO814424L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO161319C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazo-(1,5-a)pyridin-derivater.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO165104C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater.
NO153137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte pyrido(1,2-a)pyrimidiner.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO159276C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazo(1,5-a)pyridiner.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO154494C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.
NO158062C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido (1,4)benzodiazepiner.
NO822801L (no) Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furaner
NO160142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2,4)triazolo(4,3-a)kinoksalin-4-amin-derivater.
NO160136C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av benzoylfenylpiperidin.
NO165544C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2,3-dihydro-1-(8-methyl-1,2,4-triazolo-(4,3-b)pyridazin-6-yl)-4(1h)-pyridinon.